EVIRNA

N/A

Report date: 2025/01/26 17:02:45
NME

Base Information

Drug NameEVIRNA
Drug Alias NameSirRNA Inhibiting EVI1 Gene (NanoOncology)EVIRNA
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOvarian NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoOncology
China Registration ClassN/A

Develop Information

Active CompaniesNanoOncology
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A